Related Experiment Videos
New treatment strategies in advanced prostate cancer
1Department of Medicine, University of California San Francisco, USA. smalle@medicine.ucsf.edu
Abstract:
The treatment of advanced prostate cancer has evolved rapidly in the last 5 years. Therapeutic options for patients with advanced disease, once essentially limited to the use of androgen deprivation, have expanded to include a number of interventions, including secondary hormonal manipulations, chemotherapy, and a variety of investigational approaches. Novel therapeutic approaches in prostate cancer patients are likely to be undertaken in patients with disease that is at or below the limits of detection by current imaging technology, so novel methods will be essential to the successful evaluation and use of these agents.
Insights
Advanced prostate cancer treatment has expanded beyond androgen deprivation to include new hormonal therapies, chemotherapy, and investigational options. Novel methods are crucial for evaluating these treatments in early-stage disease.
Area of Science:
- Oncology
- Urology
Background:
- Advanced prostate cancer treatment was historically limited to androgen deprivation therapy.
- Recent advancements have introduced new therapeutic avenues.
Purpose of the Study:
- To review the evolving treatment landscape for advanced prostate cancer.
- To highlight the need for novel methods in evaluating new therapies.
Main Methods:
- Review of recent therapeutic advancements in advanced prostate cancer.
- Discussion of the limitations of current imaging technologies.
Main Results:
- Treatment options have significantly expanded in the last five years.
- New interventions include secondary hormonal manipulations and chemotherapy.
Conclusions:
- The development of novel therapeutic approaches is ongoing.
- Innovative methods are essential for assessing new treatments in patients with minimal disease detection.